Domchek, Susan M <br/><br/>
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancer.  [electronic resource] 

 -  Clinical advances in hematology & oncology : H&O  May 2018 
 - 330-332 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1543-0790 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>BRCA1 Protein--antagonists & inhibitors<br/>BRCA2 Protein--antagonists & inhibitors<br/>Breast Neoplasms--drug therapy<br/>Capecitabine--therapeutic use<br/>Female<br/>Furans--therapeutic use<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Indazoles--therapeutic use<br/>Indoles--therapeutic use<br/>Ketones--therapeutic use<br/>Mutation<br/>Phthalazines--therapeutic use<br/>Piperazines--therapeutic use<br/>Piperidines--therapeutic use<br/>Poly(ADP-ribose) Polymerase Inhibitors--therapeutic use<br/>Poly(ADP-ribose) Polymerases--genetics<br/>Prognosis<br/>Randomized Controlled Trials as Topic<br/>Survival Analysis<br/>Vinblastine--analogs & derivatives<br/>Vinorelbine